Three-in-one pill cuts heart failure hospitalizations by 60%
A novel three-in-one medication known as a "polypill" has been put to the test in a trial of more than 200 heart failure patients, in an effort to find a new way to effectively treat the condition with fewer drugs and better health outcomes. The findings were just what the scientists had hoped for.
Category: Heart Disease, Illnesses and conditions, Body and Mind
Tags: UT Southwestern, Heart attack, Heart, Heart Failure, Heart health, Personalized medicine, clinical trials, Experimental, Age-Related
